|
|
|
Insider
Information: |
Cohen Raymond W |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
284,273 |
|
Indirect Shares
|
692,151 |
|
|
Direct
Value |
$13,320,755 |
|
|
Indirect Value
|
$46,436,411 |
|
|
Total
Shares |
976,424 |
|
|
Total
Value |
$59,757,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
8
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
88.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cardiac Science Corp |
CSCX |
Director |
2009-05-22 |
13,825 |
|
0 |
Premium* |
|
Spectrum Pharmaceuticals Inc |
SPPI |
Director |
2019-06-20 |
53,850 |
2013-12-13 |
0 |
Premium* |
|
Biolife Solutions Inc |
BLFS |
Director |
2021-07-12 |
27,763 |
2014-05-20 |
0 |
Premium* |
|
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
188,835 |
2019-08-06 |
692,151 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SPPI |
Spectrum Pharmaceuticals ... |
Director |
|
2018-05-14 |
4 |
S |
$18.32 |
$169,918 |
D/D |
(9,275) |
28,850 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2018-05-30 |
4 |
S |
$10.15 |
$101,500 |
D/D |
(10,000) |
53,031 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2018-08-13 |
4 |
S |
$19.70 |
$197,000 |
D/D |
(10,000) |
43,031 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2018-08-21 |
4 |
S |
$23.68 |
$236,800 |
D/D |
(10,000) |
33,031 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2019-11-19 |
4 |
S |
$20.74 |
$1,555,125 |
D/D |
(75,000) |
608,391 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2020-11-12 |
4 |
S |
$32.45 |
$182,531 |
D/D |
(5,625) |
22,763 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-01-26 |
4 |
S |
$53.58 |
$420,148 |
D/D |
(7,842) |
416,389 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2021-02-01 |
4 |
S |
$51.36 |
$700,661 |
D/D |
(13,627) |
456,096 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2022-02-03 |
4 |
S |
$48.21 |
$1,694,371 |
D/D |
(35,115) |
339,635 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-13 |
4 |
S |
$65.54 |
$2,686,001 |
D/D |
(40,736) |
108,899 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-01-31 |
4 |
S |
$61.12 |
$1,400,595 |
D/D |
(22,904) |
168,713 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2023-02-01 |
4 |
S |
$60.43 |
$494,578 |
D/D |
(8,117) |
160,596 |
0 |
% |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2024-01-31 |
4 |
S |
$67.74 |
$2,381,662 |
D/D |
(35,161) |
188,835 |
0 |
% |
|
CSCX |
Cardiac Science Corp |
Director |
|
2009-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
13,825 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2017-02-06 |
4 |
OE |
$1.12 |
$20,000 |
D/D |
17,857 |
37,969 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2018-12-20 |
4 |
OE |
$1.26 |
$6,755 |
D/D |
5,357 |
38,388 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2019-04-15 |
4 |
OE |
$2.06 |
$30,900 |
D/D |
15,000 |
53,388 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2019-05-15 |
4 |
OE |
$1.90 |
$19,000 |
D/D |
10,000 |
48,388 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2019-06-17 |
4 |
OE |
$1.40 |
$7,500 |
D/D |
5,357 |
28,745 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2019-07-15 |
4 |
OE |
$1.12 |
$6,000 |
D/D |
5,357 |
28,745 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
Director |
|
2019-08-15 |
4 |
OE |
$1.12 |
$6,000 |
D/D |
5,357 |
28,745 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-01-13 |
4 |
OE |
$1.63 |
$16,300 |
D/D |
10,000 |
618,391 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
625,058 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-02-13 |
4 |
OE |
$1.63 |
$16,300 |
D/D |
10,000 |
552,058 |
0 |
- |
|
AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
|
2020-03-16 |
4 |
OE |
$1.63 |
$67,195 |
D/D |
41,224 |
583,282 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|